Description

[3-(n-Butylbutyrylamino)-2,4,6-Triiodophenyl]Acetic Acid is a high-purity, tri-iodinated organic compound primarily used as a key intermediate in the synthesis of iodinated contrast media. Its value lies in providing the essential iodine-rich aromatic core required for developing X-ray and CT imaging agents with excellent radiographic density. This advanced intermediate is critical for pharmaceutical manufacturers and R&D facilities specializing in diagnostic imaging, where consistent quality and reliable supply are paramount for downstream API production.

Application

• Pharmaceutical Intermediate: Primary building block for synthesizing non-ionic, low-osmolar iodinated contrast agents used in medical imaging.
• Diagnostic Imaging Agent Precursor: Key raw material in the production of X-ray and Computed Tomography (CT) contrast media for angiography, urography, and myelography.
• Research & Development: Used in academic and industrial labs for developing novel contrast agents with improved safety and imaging profiles.
• Chemical Synthesis: Serves as a specialized intermediate for introducing a highly functionalized, tri-iodinated phenylacetic acid moiety into complex molecules.
• Radiopharmaceutical Chemistry: Potential use in research for developing targeted imaging probes, given its high iodine content and modifiable functional groups.

Basic Information

Product Name	[3-(n-Butylbutyrylamino)-2,4,6-Triiodophenyl]Acetic Acid
CAS No.	29193-40-6
Molecular Formula	C₁₆H₂₁I₃N₂O₃
Molecular Weight	686.06 g/mol
Synonyms	3-(n-Butylbutyrylamino)-2,4,6-triiodophenylacetic acid; 2-[3-[(1-Oxopentyl)amino]-2,4,6-triiodophenyl]acetic acid; Iopanoic Acid Intermediate; Iodinated Phenylacetic Acid Derivative; B-30210; 29193-40-6; 3-(Butyrylamino)-2,4,6-triiodohydrocinnamic acid derivative
EINECS	Contact for details

Quality Control

Our [3-(n-Butylbutyrylamino)-2,4,6-Triiodophenyl]Acetic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the stringent requirements for pharmaceutical intermediate applications. Certificates of Analysis (COA) documenting purity, related substances, and residual solvents are available upon request, supporting compliance with cGMP and ICH Q7 guidelines.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated place at a controlled room temperature (15-25°C). This material is light-sensitive (store away from light) and easily oxidized (store under inert atmosphere). For long-term storage, consider packaging under an inert gas such as nitrogen or argon to maintain product integrity.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Individual Unknown Impurity	≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C
Heavy Metals	≤ 20 ppm
Loss on Drying	≤ 1.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.